We put the needs and experiences of patients at the core of our mission and purpose, working to turn cells into powerful therapeutics.
Our proprietary nicotinamide (NAM) technology leverages the properties of NAM to enhance and expand cells, creating allogeneic cell therapy products and candidates that are potentially curative for patients with hematologic malignancies.
We are pioneers with respected track records in cell therapy research and development, manufacturing and commercialization. We combine bold and creative pursuits in science with a passion for curing cancer so that patients can live longer, better lives.
You are about to leave this website for another external website outside of the control of Gamida Cell. Gamida Cell has no responsibility for the content of such other sites and is not liable for any damages or injury arising from that content. Any links to other sites are provided merely as a convenience to the users of this website.